These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 18551855

  • 1. Outpatient management of febrile neutropenia: time to revise the present treatment strategy.
    Carstensen M, Sørensen JB.
    J Support Oncol; 2008; 6(5):199-208. PubMed ID: 18551855
    [Abstract] [Full Text] [Related]

  • 2. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.
    Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427
    [Abstract] [Full Text] [Related]

  • 3. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gómez C, Ruiz A, García-Carbonero R, Cortés-Funes H.
    Cancer; 1999 Jan 01; 85(1):213-9. PubMed ID: 9921995
    [Abstract] [Full Text] [Related]

  • 4. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalami Y, Aoun M, Barette M.
    J Clin Oncol; 2006 Sep 01; 24(25):4129-34. PubMed ID: 16943529
    [Abstract] [Full Text] [Related]

  • 5. Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia.
    Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G.
    Ann Hematol; 2007 Apr 01; 86(4):263-70. PubMed ID: 17225113
    [Abstract] [Full Text] [Related]

  • 6. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G, Sunderland T, Chan KW, Rolston K, Mullen CA.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):273-7. PubMed ID: 16435377
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb 01; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 11. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia].
    Karthaus M, Meran JG, Geissler RG, Böhme A, Jürgens H, Ganser A.
    Wien Med Wochenschr; 1998 Feb 01; 148(18):427-32. PubMed ID: 9888179
    [Abstract] [Full Text] [Related]

  • 12. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec 01; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 13. Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study.
    Ahmed N, El-Mahallawy HA, Ahmed IA, Nassif S, El-Beshlawy A, El-Haddad A.
    Pediatr Blood Cancer; 2007 Nov 01; 49(6):786-92. PubMed ID: 17366527
    [Abstract] [Full Text] [Related]

  • 14. Retrospective review of gynecologic oncology patients with therapy-induced neutropenic fever.
    McMeekin DS, Gazzaniga C, Berman M, DiSaia P, Manetta A.
    Gynecol Oncol; 1996 Aug 01; 62(2):247-53. PubMed ID: 8751557
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Outpatient therapy for febrile neutropenia.
    Innes H, Marshall E.
    Curr Opin Oncol; 2007 Jul 01; 19(4):294-8. PubMed ID: 17545790
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The medical course of cancer patients with fever and neutropenia. Clinical identification of a low-risk subgroup at presentation.
    Talcott JA, Finberg R, Mayer RJ, Goldman L.
    Arch Intern Med; 1988 Dec 01; 148(12):2561-8. PubMed ID: 3196123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.